Helix Biopharma Corp.
HBP.TO
TSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.38M | 163.60K | 782.60K | 516.60K | 89.70K |
| Total Receivables | 23.50K | 25.80K | 39.10K | 64.00K | 47.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 139.60K | 100.50K | 232.40K | 227.70K | 91.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.54M | 289.90K | 1.05M | 808.40K | 228.70K |
|
|
|||||
| Total Current Assets | 1.54M | 289.90K | 1.05M | 808.40K | 228.70K |
| Net Property, Plant & Equipment | 13.10K | 6.50K | 23.20K | 24.70K | 28.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 700.00 | 700.00 | 700.00 | 0.00 | 0.00 |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.55M | 297.10K | 1.08M | 833.10K | 257.10K |
|
|
|||||
| Total Accounts Payable | 2.56M | 709.00K | 619.00K | 793.10K | 250.40K |
| Total Accrued Expenses | 567.30K | 566.90K | 524.10K | 265.60K | 200.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 36.40K | -- |
| Total Other Current Liabilities | -- | -- | -- | 36.40K | -- |
| Total Current Liabilities | 1.56M | 1.28M | 1.14M | 1.10M | 450.70K |
|
|
|||||
| Total Current Liabilities | 1.56M | 1.28M | 1.14M | 1.10M | 450.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.56M | 1.28M | 1.14M | 1.10M | 450.70K |
|
|
|||||
| Common Stock & APIC | 144.12M | 147.40M | 149.08M | 147.37M | 150.10M |
| Retained Earnings | -147.43M | -152.14M | -152.51M | -149.44M | -152.15M |
| Treasury Stock & Other | 3.30M | 3.76M | 3.37M | 1.81M | 1.86M |
| Total Common Equity | -13.10K | -978.80K | -65.20K | -261.90K | -193.60K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.10K | -978.80K | -65.20K | -261.90K | -193.60K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.10K | -978.80K | -65.20K | -261.90K | -193.60K |
|
|
|||||